Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
- RxCUI
- 1812945
- RxNorm name
- Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
- Display name
- Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
- Full name
- Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125597 | Vaxchora | Cholera Vaccine, Live, Oral | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2d33d9ae-1fe6-477e-9285-8890f6e98be4 | Vibrio cholerae CVD 103-HGR strain live antigen 12,000,000 UNT/mL Oral Suspension [PSN] · Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension [SCD] | 2 | 3 | These highlights do not include all the information needed to use VAXCHORA safely and effectively. See full prescribing information for VAXCHORA. VAXCHORA ® (Cholera Vaccine, Live, Oral) Suspension for Oral Administration Initial U.S. Approval: 2016 | 20250207 |